Nantahala Capital Management, LLC Ventyx Biosciences, Inc. Transaction History

Nantahala Capital Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$29.8 - $40.3 $1.34 Million - $1.82 Million	-45,048 Reduced 23.38%	147,623 $5.13 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $1.02 Million - $1.62 Million	34,638 Added 21.92%	192,671 $6.45 Million
Q4 2022 Feb 14, 2023	BUY	$24.16 - $36.38 $1 Million - $1.51 Million	41,400 Added 35.5%	158,033 $5.18 Million
Q3 2022 Nov 10, 2022	BUY	$12.64 - $38.7 $1.47 Million - $4.51 Million	116,633 New	116,633 $4.07 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $135M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nantahala Capital Management, LLC with notifications on news.